Location History:
- Tokyo, JP (2010 - 2014)
- Kunitachi, JP (2014 - 2015)
Company Filing History:
2 out of 35,734 
2 out of 11 
1 out of 1,310 
Years Active: 2010-2015
Title: Innovations by Kosuke Oikawa
Introduction
Kosuke Oikawa is a notable inventor based in Kunitachi, Japan. He has made significant contributions to the field of cancer research, holding a total of 4 patents. His work focuses on developing novel cancer markers and evaluation methods that can aid in the diagnosis and treatment of various cancers.
Latest Patents
Oikawa's latest patents include a cancer marker and a method for evaluating cancer using this marker. The invention provides a novel cancer marker for assessing the onset, preclinical stage, clinical stage, or prognosis of cancer in a subject. This cancer marker includes at least one miRNA selected from hsa-miR-92 and hsa-miR-494, specifically for cancers excluding breast cancer. The evaluation method involves detecting the expression level of this cancer marker in a biological sample collected from a subject. Additionally, he has developed a cancer cell identification marker and a cancer cell proliferation inhibitor. This identification marker is utilized for detecting various human cancer cells and is closely related to the malignant alteration of cells. The marker is human heterochromatin protein 1γ (HP1γ), and the treatment compositions are based on suppressing cancer cell proliferation through inhibition of the expression of this identification marker.
Career Highlights
Throughout his career, Kosuke Oikawa has worked with prominent organizations such as NEC Corporation and Tokyo Medical University. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in cancer diagnostics and treatment.
Collaborations
Oikawa has collaborated with notable individuals in his field, including Masahiko Kuroda and Masakatsu Takanashi. These collaborations have further enriched his research and development efforts.
Conclusion
Kosuke Oikawa's innovative work in cancer research has the potential to significantly impact the diagnosis and treatment of cancer. His contributions through his patents demonstrate his commitment to advancing medical science and improving patient outcomes.